Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer

Clinical Cancer Research

Volumn 10, Issue 14, 2004, Pages 4799-4805

  Kamai, Takao ^a,b   Yamanishi, Tomonori ^a   Shirataki, Hiromichi ^a   Takagi, Kentaro ^b   Asami, Hidekazu ^b   Ito, Yuji ^b   Yoshida, Ken Ichiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Tokyo Metropolitan Tama Geriatric Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; PROTEIN; PROTEIN CDC42; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ROCK I PROTEIN; ROCK II PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CYTOSKELETON; GENE OVEREXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TESTIS CANCER; WESTERN BLOTTING;

ADOLESCENT; ADULT; BLOTTING, WESTERN; CDC42 GTP-BINDING PROTEIN; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RAC1 GTP-BINDING PROTEIN; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; TESTICULAR NEOPLASMS;

EID: 3242699514     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0436-03     Document Type: Article

References (34)

1. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337:242-53.
2. Motzer RJ, Geller NL, Tan CC, et al. Salvage chemotherapy for patients with germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer (Phila.) 1991;67:1305-10.
3. Broun ER, Nichols CR, Kneebone P, et al. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 1992;117:124-8.
4. Motzer RJ, Bosl GJ. High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions. J Natl Cancer Inst (Bethesda) 1992;84:1703-9.
5. Quigley JP, Armstrong PB. Tumor cell intravasation alu-cidated; the chick embryo opens the window. Cell 1998;94:281-4.
6. Hall A. Rho GTPases and the actin cytoskeleton. Science (Wash. DC) 1998;279:509-14.
7. Van Aelst L, D'Souza-Schorey C. Rho GTPases and signaling networks Genes Dev 1997;11:2295-322.
8. Sahai E, Marshall CJ. Rho-GTPases and cancer. Nat Rev Cancer 2002;2:133-42.
9. Fritz G, Just I, Kaina B. Rho GTPase over-expressed in human tumors. Int J Cancer 1999;81:682-7.
10. Kamai T, Tsujii T, Arai K, et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 2003;9:2632-41.
11. Kamai T, Kawakami S, Koga F, et al. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int 2003;91:234-8.
12. Abraham MT, Kuriakose MA, Sacks PG, et al. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 2001;111:1285-9.
13. Ishizaki T, Maekawa M, Fujisawa K, et al. The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO, J 1996;15:1885-93.
14. Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J 2000;348:241-55.
15. Ishizaki T, Naito M, Fujisawa K, et al. p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett 1997;404:118-24.
16. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999;5:221-5.
17. Imamura F, Mukai M, Ayaki M, Akedo H. Y-27632, an inhibitor of Rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase. Jpn J Cancer Res 2000;91:811-6.
18. Nobes CD, Hall A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
19. th ed. New York: Wiley. 1997. p. 174-9.
20. Matsui T, Amano M, Yamamoto T, et al. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for the small GTP binding protein Rho. EMBO J 1996;15:2208-16.
21. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serin/threonine kinase in mice. FEBS Lett 1996;392:189-93.
22. Kamai T, Arai K, Sumi S, et al. The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour. BJU Int 2002;89:449-53.
23. del Peso L, Hernandez-Alcoceba R, Embade N, et al. Rho proteins induce metastatic properties in vivo. Oncogene 1997;15:3047-57.
24. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eight G. H. A. Clowes Memorial Award Lecture. Cancer Res 1990;50:6130-8.
25. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (Lond.) 1997;389:990-4.
26. Ishizaki T, Uehata M, Tamechika I, et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000;57:976-83.
27. Banyard J, Anand-Apte B, Symons M, Zetter BR. Motility and invasion are differently modulated by Rho family GTPases. Oncogene 2000;19:580-91.
28. Evers EE, Zondag GCM, Malliri A, et al. Rho family proteins in cell adhesion and cell migration. Eur J Cancer 2000;36:1269-74.
29. Yoshioka K, Nakamori S, Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999;59:2004-10.
30. Mackay DJ, Hall A. Rho GTPases. J Biol Chem 1998;273:20685-8.
31. Anastasiadis PZ, Moon SY, Thoreson MA, et al. Inhibition of RhoA by p120 catenin. Nat Cell Biol 2000;2:637-44.
32. Noren NK, Liu BP, Burridge K, Kreft B. p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 2000;150:567-80.
33. Grosheva I, Shtutman M, Elbaum M, Bershadsky AD. p120 catenin affects cell motility via modulation of activity of Rho-family GTPases: a link between cell-cell contact formation and regulation of cell locomotion. J Cell Sci 2000;114:695-707.
34. Nishimura M, Machida K, Imaizumi M, et al. Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis. Br J Cancer 1996;74:780-7.